BC
Broadwood Capital Portfolio holdings
AUM
$1.65B
1-Year Est. Return
54.78%
1 Year Est. Return
+54.78%
AUM
$1.65B
AUM Growth
+$118M
(+7.7%)
Holding
13
Top Buys
No buys this quarter
Top Sells
| 1 | +$33.7M | |
| 2 | +$545K | |
| 3 | +$337K | |
| 4 |
Serina Therapeutics
SER
|
+$10.8K |
Sector Composition
| 1 | Consumer Staples | 33.59% |
| 2 | Industrials | 30.1% |
| 3 | Healthcare | 29.36% |
| 4 | Consumer Discretionary | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$73.6B
| $555M | 33.42% |
8,250,428
-5,000
|
|
||
2
Axon Enterprise
AXON
$44.7B
| $498M | 29.95% |
693,504
-760
|
|
||
3
STAAR Surgical
STAA
$1.19B
| $363M | 21.86% |
13,519,491
|
|
||
4
iShares Russell 2000 ETF
IWM
$72.9B
| $115M | 6.92% |
474,920
|
|
||
5
Lineage Cell Therapeutics
LCTX
$401M
| $83.8M | 5.04% |
49,560,992
|
|
||
|
IMDX
6
Insight Molecular Diagnostics
IMDX
$146M
| $37.9M | 2.28% |
11,410,100
|
|
||
|
7
Serina Therapeutics
SER
$30M
| $446K | 0.03% |
83,195
-2,024
|
|
||
8
American Airlines Group
AAL
$10.2B
| – | – |
0
|
|
||
9
Delta Air Lines
DAL
$46.1B
| – | – |
0
|
|
||
|
HBI
10
DELISTED
Hanesbrands
HBI
| – | – |
0
|
|
||
11
Southwest Airlines
LUV
$21.2B
| – | – |
0
|
|
||
|
OLO
12
DELISTED
Olo Inc
OLO
| – | – |
-3,782,821
|
|
||
13
United Airlines
UAL
$36.9B
| – | – |
0
|
|